dc.contributor.author | Rubio, María. | |
dc.contributor.author | Travaglianti, Mónica. | |
dc.date.accessioned | 2020-12-01T21:07:45Z | |
dc.date.available | 2020-12-01T21:07:45Z | |
dc.date.issued | 2020-04-01 | |
dc.identifier.citation | Rev Enferm Neonatal. 2020;32:27-39. | en_US |
dc.identifier.issn | 2591-6424 | |
dc.identifier.uri | https://riu.austral.edu.ar/handle/123456789/1010 | |
dc.description.abstract | Hospitalized children are exposed to multiple pain-
ful procedures. Each care center should implement a
comprehensive program for the prevention and ma-
nagement of pain in the newborn that includes us-
ing strategies for routine evaluation, minimizing the
number of painful procedures, reducing exposure to
environmental stimuli such as light and noise, and us-
ing protocols that incorporate the use of non-pharma-
cological and pharmacological measures effectively.
With regard to the administration of drugs, it is essen-
tial to carefully select those who present greater evi-
dence of efficacy and safety.
Neonates constitute the population with the least in-
formation regarding the dose, pharmacokinetic and
pharmacodynamic behavior of medications because
there are few robust clinical studies in patients of this
age range.
However, knowing the characteristics of the medi-
cations currently available for the management of
sedo-analgesia in the neonatal population is a funda-
mental objective for the proper, safe and efficient use
of these drugs.
This article develops the most frequently used in this
population. | en_US |
dc.description.sponsorship | Acceso Free: https://drive.google.com/file/d/1rwPaCVxRN-e54DzAaaamdmF-CVRqXSpg/view | en_US |
dc.language.iso | es | en_US |
dc.publisher | FUNDASAMIN (Fundación para la Salud Materno Infantil) | en_US |
dc.subject | Pain | en_US |
dc.subject | Neonate | en_US |
dc.subject | Pharmacological treatment | en_US |
dc.subject | Analgesics | en_US |
dc.title | Tratamiento farmacológico del dolor del recién nacido | en_US |
dc.type | Article | en_US |